Our chromatin immunoprecipitation (ChIP) analyses demonstrated a clear binding of MTF-1 to ZIP14, with a noteworthy increase in binding percentage observed in the fibrosis group following ZnCl2 treatment, but not in the sham group (Fig. 5A). Here, SLC39A14 is linked to fibrosis.